Joint consensus report on adult influenza from five specialty associations
Five specialty associations in Turkey have published a comprehensive consensus report addressing the health burden of influenza, highlighting the vital importance of vaccination.
Five different specialty associations in Turkey prepared a joint consensus report aiming to reduce the effects of influenza on public health and to provide guidance in diagnosis and treatment processes. The report emphasized that the disease should not be confused with the common cold and recommended vaccination for everyone over 6 months of age.
Purpose of the Consensus Report
Five specialty associations from different medical fields in Turkey came together to draw attention to the serious health burden caused by influenza. A joint study was conducted to determine current approaches in diagnosis, treatment, prevention of complications, and immunization processes in adults.
Experts Leading the Study
The report was prepared with the joint contributions of representatives from the Turkish Family Physicians Specialty Association, the Turkish Infectious Diseases and Clinical Microbiology Specialty Association, the Turkish Endocrinology and Metabolism Association, the Eurasian Heart Failure Association, and the Turkish Internal Medicine Specialists Association.
Global Health Burden
According to World Health Organization data, approximately 1 billion people worldwide are affected by seasonal influenza each year. In a significant portion of these cases, severe disease conditions develop, and hundreds of thousands of deaths occur annually due to respiratory illnesses.
Difference Between Common Cold and Influenza
The consensus report specifically states that the clinical picture of influenza should not be confused with a simple common cold. It is stated that the disease starts suddenly and manifests itself with prominent symptoms such as fever, chills, and muscle aches.
Vaccination and Prevention Strategies
Vaccination stands out as the most effective way to protect against the disease, which can lead to life-threatening risks such as pneumonia and respiratory failure in individuals in risk groups. It was noted that vaccination is recommended for everyone over 6 months of age and that the most appropriate period is the autumn months.